Zometa 4 mg Lyophilisat
Country: Switzerland
Language: German
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Säure zoledronicum
Available from:
Novartis Pharma Schweiz AG
ATC code:
M05BA08
INN (International Name):
acid zoledronicum
Pharmaceutical form:
Lyophilisat
Composition:
Praeparatio cryodesiccata: acidum zoledronicum 4.000 mg ut acidum zoledronicum monohydricum, mannitolum, natrii citras dihydricus corresp. natrium 6.41 mg, pro vitro. Solvens: aqua ad iniectabilia.
Class:
B
Therapeutic group:
Synthetika
Therapeutic area:
Knochenmetastasen solider Tumoren und multiples Myelom, maligne Hypercalcämie
Authorization status:
zugelassen
Authorization date:
2000-11-28
